A Convenient Method for Solubilization and Refolding Recombinant Proteins: An Experience from Recombinant Mouse TGF-β1
The production of recombinant proteins in Escherichia coli is one of the most valuable achievements in biotechnology, with many therapeutic and diagnostic applications; however, the aggregation and misfolding of proteins that result in the formation of insoluble inclusion bodies is a disruptive factor in this process. Various solubilization and refolding methods can be used to improve recombinant protein conformation. In this study, we applied a dilution method with a refolding buffer to produce a native form of soluble immature mouse TGF-β1.
The TGF-β1 cDNA which encodes the protein without the signal peptide, was cloned into the pET21-b (+) vector. The target protein was expressed by the transformation of E. coli BL21 cells with the plasmid. The resulting inclusion bodies were solubilized and then diluted in the refolding buffer to make a protein with native structure.
Following PCR of the recombinant plasmid with T7 primers, electrophoresis and sequencing of the amplified product indicated 100% identity of the target sequence with the murine TGF-β1 gene. Finally, the protein solubility and immuno-reactivity were confirmed a 44 kDa protein which conducted with the anti-TGF-β1-specific polyclonal antibody on a western blot.
Our dilution method and refolding buffer effectively converted aggregated immature mouse TGF-β1 to a soluble and immuno-reactive form.
-
Seroprevalence of Anti-SARS-CoV-2 IgG Antibody in Healthcare Workers: A Report From Rafsanjan City
Mahnaz Tashakori, Ahmad Jamalizadeh, Mohsen Nejad-Ghaderi, Maryam Hadavi, Aliakbar Yousefi-Ahmadipour, Fatemeh Mohseni Moghadam, Athareh Soresrafil, *
Journal of Inflammatory Diseases, Winter 2022 -
Cloning, Expression, and Purification of Recombinant Mouse Interferon-γ
Seyedeh Elham Badiee Kheirabadi, , Malihe Moghadam, Mohammad Javad Mousavi*, Mojtaba Sankian
Research in Molecular Medicine, Feb 2021